Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Metformin Dose in PCOS
NCT07120815Phase 3Not yet recruiting
- Sponsor
- Helsinki University Hospital
- Start
- Sep 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in polycystic ovary syndrome (PCOS), sponsored by Helsinki University Hospital. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07120815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07120815.